<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>新冠特效药 on 桂启洪个人网站</title>
    <link>https://www.guiqihong.com/tags/%E6%96%B0%E5%86%A0%E7%89%B9%E6%95%88%E8%8D%AF/</link>
    <description>Recent content in 新冠特效药 on 桂启洪个人网站</description>
    <generator>Hugo</generator>
    <language>zh</language>
    <lastBuildDate>Thu, 09 Dec 2021 03:41:38 +0000</lastBuildDate>
    <atom:link href="https://www.guiqihong.com/tags/%E6%96%B0%E5%86%A0%E7%89%B9%E6%95%88%E8%8D%AF/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>首个国产新冠特效药获批，新冠疫苗还要打吗？</title>
      <link>https://www.guiqihong.com/5569.html</link>
      <pubDate>Thu, 09 Dec 2021 03:41:38 +0000</pubDate>
       <guid isPermaLink="false">https://www.guiqihong.com/?p=5569</guid> 
      <description>12月8日晚，国家药监局官网公布，我国首个自主知识产权新冠病毒中和抗体联合治疗药物——安巴韦单抗注射液（BRII-196）及罗米司韦单抗注射液（BRII-198）获批。</description>
    </item>
  </channel>
</rss>
